<DOC>
	<DOCNO>NCT02091388</DOCNO>
	<brief_summary>This study assess bioavailability LY03004 compare Risperdal Consta well evaluate safety tolerability preliminary efficacy LY03004 repeat injection</brief_summary>
	<brief_title>Bioavailability LY03004 Risperdal® Consta®</brief_title>
	<detailed_description>- To assess relative bioavailability LY03004 compare Risperdal® Consta® 25 mg follow multiple intramuscular injection steady-state ; - To evaluate safety tolerability LY03004 follow repeat intramuscular injection - To evaluate preliminary efficacy LY03004 follow repeat intramuscular injection</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Male female patient age 18 65 year old 2 . Patients must DSMIVTR diagnosis schizophrenia schizoaffective disorder base MiniInternational Neuropsychiatric Interview ( MINI ) 3 . Patients must clinically stable antipsychotic medication risperidone paliperidone clozapine least 4 week prior screen , base clinical assessment AND Positive Negative Syndrome Scale ( PANSS ) total score less equal 70 Screening Visit 4 . Patients Body Mass Index range 18.0 35.0 5 . Patients Informed Consent Form sign patient legally authorize representative 1 . Patients mental disorder schizophrenia schizoaffective disorder , accord DSMIVTR 2 . Patients receive oral risperidone paliperidone clozapine within 14 day prior screen , Risperdal® Consta® within 100 day prior screen paliperidone palmitate within 10 month prior screen 3 . Patients neuroleptic malignant syndrome physical fatigue associate dehydration malnutrition 4 . Patients pose significant risk suicide attempt base history , investigator 's judgment answer `` yes '' question 4 5 current past 30 day screen form Columbia Suicide Severity Rating Scale ( CSSRS ) 5 . Patients history sensitivity akathisia EPS , especially previous use risperidone paliperidone 6 . Patients uncontrolled diabetes mellitus indicate HbA1c level great equal 7 % 7 . Patients history currently epilepsy convulsion disorder 8 . Patients electroconvulsive therapy within past 2 month prior screen 9 . Patients used medication know inducer inhibitor CYP 2D6 within 2 week prior screen 10 . Patients history allergic reaction risperidone excipients LY03004 11 . Patients meet DSMIVTR criterion substance abuse dependence exception caffeine nicotine past 6 month prior screen 12 . Patients history clinically relevant cardiac arrhythmia 's , cardiovascular disease , thyrotoxicosis , parkinsonism , hemorrhagic diathesis 13 . Patients currently take medication primarily CNS activity antidepressant , mood stabilizer anticonvulsants 14 . Patients participate clinical trial another investigational drug within 30 day prior screen 15 . Female patient pregnant breastfeed childbearing potential without adequate use contraception 16 . Patients clinically relevant hepatic , renal cardiac dysfunction , medical condition laboratory abnormality , judgment investigator would interfere subject 's ability participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>